(Q31857397)

4 July 2017

title

Fatal pulmonary veno-occlusive disease possibly related to gemcitabine (English)

1 reference

4 July 2017

J F Vansteenkiste

1 reference

4 July 2017

P Bomans

1 reference

4 July 2017

E K Verbeken

1 reference

4 July 2017

K L Nackaerts

1 reference

4 July 2017

M G Demedts

1 reference

4 July 2017

publication date

1 January 2001

1 reference

4 July 2017

1 reference

4 July 2017

1 reference

4 July 2017

1 reference

4 July 2017

page(s)

83-85

1 reference

Phase II study of docetaxel alternating with cisplatin in chemotherapy-naïve patients with advanced non-small cell lung cancer

4 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900159-8

7 January 2021

Veno-occlusive disease of the liver induced by gemcitabine

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900159-8

7 January 2021

Fatal pulmonary toxicity resulting from treatment with gemcitabine

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900159-8

7 January 2021

Hemolytic-uremic syndrome caused by gemcitabine

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900159-8

7 January 2021

Pulmonary veno-occlusive disease after chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900159-8

7 January 2021

Pulmonary veno-occlusive disease following therapy for malignant neoplasms

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900159-8

7 January 2021

10.1016/S0169-5002(00)00159-8

Identifiers

DOI

1 reference

4 July 2017

1 reference